Comparison of Efficacy of Dexamethasone and Methylprednisolone in Moderate to Severe Covid 19 Disease
Status:
Completed
Trial end date:
2020-07-01
Target enrollment:
Participant gender:
Summary
The investigator will select participants with moderate to severe covid 19 disease admitted
in Fatima memorial hospital. The investigator will divide them in two groups according to
convenience sampling. Group 1 will be given dexamethasone 8mg/day and group 2 will be given
methylprednisolone 1mg/kg/day IV for 5 days. The investigator will compare the improvement in
temperature, oxygen requirement and CRP level at day zero and day 5 in both the groups.